7Baggers

Co-Diagnostics Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20190331 20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 -11.99-5.980.036.0512.0618.0724.0930.1Milllion

Co-Diagnostics Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 
  revenue3,555,177 2,457,098 197,806 601,957 1,401,483 5,094,456 5,023,226 22,699,044 20,401,341 30,101,353 27,358,140 20,024,769 27,145,203 21,818,753 24,040,274 1,548,528 108,566 41,434 61,574 3,400 10,823 9,696 9,696 9,696 2,598 2,598 2,466 
  cost of revenue3,280,719 255,772 459,095 502,241 515,773 767,936 915,432 3,281,951 2,486,769 3,311,255 2,504,355 3,272,565 4,313,020 5,821,281 8,344,674 481,740 52,805 20,365 38,809 452 9,391 0 0 0 0 0 302 
  gross profit274,458 2,201,326 -261,289 99,716 885,710 4,326,520 4,107,794 19,417,093 17,914,572 26,790,098 24,853,785 16,752,204 22,832,183 15,997,472 15,695,600 1,066,788 55,761 21,069 22,765 2,948 1,432 9,696 9,696 9,696 2,598 2,598 2,164 
  operating expenses                           
  research and development6,178,701 5,788,789 5,981,043 5,014,060 4,739,466 5,037,461 3,889,844 3,771,327 2,182,343 5,893,350 4,669,160 2,217,063 1,113,130 921,889 750,249 400,022 380,510 331,027 312,590 347,306 375,428 330,422 357,889 297,415 281,390 272,209 184,880 
  sales and marketing1,517,123 1,904,395 1,732,966 1,706,331 1,330,348 1,889,907 1,472,225 2,652,148 2,093,863 4,253,091 5,853,313 1,197,546 3,207,965 798,474 390,191 268,483 291,137 262,360 252,076 256,103 746,221 180,257 143,890 95,263 119,790 117,078 125,626 
  general and administrative                           
  total operating expenses4,403,828 3,147,753 3,713,895 3,013,965 5,250,075 3,622,273 2,468,421 2,922,195 3,226,995 2,919,498 2,468,433 2,935,689 2,424,799 2,203,417 2,191,034 1,459,484 988,378 1,060,763 807,769 640,363 689,902 1,150,170 848,668 882,046 1,082,578 1,405,955 381,524 
  operating income12,099,652 11,137,277 11,733,150 10,050,366 11,618,507 10,862,135 8,254,832 9,592,934 7,605,807 13,159,977 13,062,620 6,417,303 6,803,073 3,959,270 3,356,692 2,148,737 1,679,159 1,671,156 1,388,529 1,257,440 1,824,682 1,673,465 1,363,062 1,287,127 1,496,288 1,807,658 703,116 
  net income-11,825,190 -8,935,951 -11,994,439 -9,950,650 3,835,551 -6,535,615 -4,147,038 6,537,690 10,308,765 13,630,121 11,791,165 10,334,901 16,029,110 12,038,202 12,338,908 -1,081,949 -1,623,398 -1,650,087 -1,365,764 -1,254,492 -1,823,250 -1,663,769 -1,353,366 -1,277,431 -1,493,690 -1,805,060 -700,952 

We provide you with 20 years income statements for Co-Diagnostics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Co-Diagnostics stock. Explore the full financial landscape of Co-Diagnostics stock with our expertly curated income statements.

The information provided in this report about Co-Diagnostics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.